JP2010509306A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010509306A5 JP2010509306A5 JP2009535815A JP2009535815A JP2010509306A5 JP 2010509306 A5 JP2010509306 A5 JP 2010509306A5 JP 2009535815 A JP2009535815 A JP 2009535815A JP 2009535815 A JP2009535815 A JP 2009535815A JP 2010509306 A5 JP2010509306 A5 JP 2010509306A5
- Authority
- JP
- Japan
- Prior art keywords
- ansamycin
- pharmaceutically acceptable
- acceptable salt
- represent
- ome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0622342.4A GB0622342D0 (en) | 2006-11-09 | 2006-11-09 | Novel compounds and methods for their production |
| GB0720875A GB0720875D0 (en) | 2007-10-24 | 2007-10-24 | Novel compounds and methods for their production |
| PCT/GB2007/050679 WO2008056188A2 (en) | 2006-11-09 | 2007-11-09 | Novel compounds and methods for their production |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010509306A JP2010509306A (ja) | 2010-03-25 |
| JP2010509306A5 true JP2010509306A5 (https=) | 2010-12-16 |
Family
ID=39362724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009535815A Pending JP2010509306A (ja) | 2006-11-09 | 2007-11-09 | 新規化合物及びそれらの製造方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8492370B2 (https=) |
| EP (1) | EP1973883B1 (https=) |
| JP (1) | JP2010509306A (https=) |
| KR (1) | KR20090075856A (https=) |
| AU (1) | AU2007319014B2 (https=) |
| BR (1) | BRPI0718564A2 (https=) |
| CA (1) | CA2669047A1 (https=) |
| ES (1) | ES2389740T3 (https=) |
| MX (1) | MX2009004775A (https=) |
| WO (1) | WO2008056188A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101688227B (zh) * | 2007-01-26 | 2013-07-24 | 科森生物科学公司 | 通过工程化生物合成制备的大环内酰胺 |
| KR101097850B1 (ko) | 2009-02-24 | 2011-12-23 | 한국생명공학연구원 | 젤다나마이신 생합성 조절유전자 변이주 및 이를 이용한 젤다나마이신 생산방법 |
| CN117695374B (zh) * | 2024-01-25 | 2024-09-06 | 超越健康科技(浙江)有限公司 | 一种用于治疗帕金森病的生物药物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI943207A0 (fi) * | 1992-01-06 | 1994-07-05 | Pfizer | 4,5-dihydrogeldanamysiinin ja sen hydrokinonin valmistusmenetelmä ja käyttö |
| EP1472230B1 (en) * | 2002-02-08 | 2009-06-17 | Conforma Therapeutic Corporation | Ansamycins having improved pharmacological and biological properties |
| BRPI0418147A (pt) * | 2003-12-23 | 2007-04-17 | Infinity Pharmaceuticals Inc | análogos de ansamicinas contendo benzoquinona e seus métodos de uso |
| JPWO2005061461A1 (ja) * | 2003-12-24 | 2007-07-12 | 協和醗酵工業株式会社 | ヒートショックプロテイン９０（ｈｓｐ９０）ファミリー蛋白質阻害剤 |
| EP1863769A4 (en) | 2005-03-11 | 2009-03-18 | Univ Colorado | HSP90 INHIBITORS, METHOD FOR THE PRODUCTION THEREOF AND THEIR APPLICATIONS |
| WO2007001049A1 (ja) * | 2005-06-29 | 2007-01-04 | Kyowa Hakko Kogyo Co., Ltd. | ベンゼノイドアンサマイシン誘導体 |
| BRPI0620624A2 (pt) * | 2005-12-24 | 2011-11-16 | Biotica Tech Ltd | análogo de 21-deóximacbecina ou um sal farmaceuticamente aceitável do mesmo, método para a produção do mesmo, composição farmacêutica, cepas hospedeira e engenheirada, e, uso das mesmas |
| CN101012196A (zh) * | 2006-12-27 | 2007-08-08 | 中国人民解放军军事医学科学院毒物药物研究所 | 芳香化格尔德霉素类衍生物及其制备方法和用途 |
| CN101688227B (zh) * | 2007-01-26 | 2013-07-24 | 科森生物科学公司 | 通过工程化生物合成制备的大环内酰胺 |
-
2007
- 2007-11-09 BR BRPI0718564-2A patent/BRPI0718564A2/pt not_active IP Right Cessation
- 2007-11-09 EP EP07824891A patent/EP1973883B1/en not_active Not-in-force
- 2007-11-09 CA CA002669047A patent/CA2669047A1/en not_active Abandoned
- 2007-11-09 ES ES07824891T patent/ES2389740T3/es active Active
- 2007-11-09 WO PCT/GB2007/050679 patent/WO2008056188A2/en not_active Ceased
- 2007-11-09 AU AU2007319014A patent/AU2007319014B2/en not_active Ceased
- 2007-11-09 KR KR1020097009593A patent/KR20090075856A/ko not_active Ceased
- 2007-11-09 MX MX2009004775A patent/MX2009004775A/es active IP Right Grant
- 2007-11-09 US US12/513,967 patent/US8492370B2/en active Active
- 2007-11-09 JP JP2009535815A patent/JP2010509306A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102820455B1 (ko) | Shp2 활성 억제용 화합물의 제조 방법 | |
| AU2015243379B2 (en) | Tubulysin derivatives | |
| CN101641117B (zh) | 药物组合物 | |
| JP2022071010A (ja) | アルギナーゼ活性を阻害する組成物及び方法 | |
| JP2025114615A (ja) | 治療薬としての細胞毒素のペプチドコンジュゲート | |
| JP6773915B2 (ja) | 前立腺癌を治療する組み合わせ、薬物組成物および治療方法 | |
| JP2019525962A (ja) | ケモカイン受容体調節剤及びそれの使用 | |
| EA038192B1 (ru) | Фармацевтические композиции, содержащие диастереомеры макролида, способы их синтезирования и терапевтическое применение | |
| JP6557744B2 (ja) | 抗腫瘍剤及び抗腫瘍効果増強剤 | |
| JP2019505548A (ja) | Ｍｙｃモジュレーターとしてのｍａｘバインダーおよびこれらの使用 | |
| MX2012009894A (es) | Inhibidores dimericos de iap. | |
| JP2011517455A (ja) | Ｃ（１０）エチルエステルおよびｃ（１０）シクロプロピルエステル置換タキサン | |
| JP2009536181A5 (https=) | ||
| AU2020343329C1 (en) | Methods of treatment | |
| EP3101020B1 (en) | Deuterated quinazolinone compound and pharmaceutical composition comprising same | |
| JP2010509306A5 (https=) | ||
| JPWO2021007435A5 (https=) | ||
| JP2009536934A5 (https=) | ||
| AU2019318046A1 (en) | Histone demethylase 5 inhibitors and uses thereof | |
| EP3179998B1 (en) | Compounds for the treatment of hpv-induced carcinoma | |
| CN1533273A (zh) | 紫杉烷类药物的节拍式给药 | |
| HK40095791A (en) | Process of manufacture of a compound for inhibiting the activity of shp2 | |
| HK40128848A (zh) | 用於治疗癌症的化合物 | |
| BR122025028707A2 (pt) | Métodos para produção de compostos para inibir atividade de shp2 | |
| RU2020138336A (ru) | Ингибиторы рецепторов erbb |